Abingdon, United Kingdom

Susan Adele Greenfield

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 1.8

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Oxford, GB (2018 - 2021)
  • Abingdon, GB (2019 - 2024)

Company Filing History:


Years Active: 2018-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Susan Adele Greenfield

Introduction

Susan Adele Greenfield is a prominent inventor based in Abingdon, GB. She has made significant contributions to the field of neurodegenerative disorders, holding a total of 9 patents. Her work focuses on developing novel therapies and methods to treat conditions such as Alzheimer's disease.

Latest Patents

Among her latest patents is a cyclic polypeptide, derivative, or analogue thereof, which comprises an amino acid sequence derived from the C-terminus of acetylcholinesterase (AChE), or a truncation thereof. Additionally, she has developed modified peptides aimed at treating neurodegenerative disorders, which include innovative compositions and therapies for conditions like Alzheimer's disease.

Career Highlights

Susan is currently associated with Neuro-bio Ltd, where she continues to push the boundaries of research in neurodegenerative disorders. Her dedication to this field has led to groundbreaking discoveries that have the potential to improve the lives of many individuals affected by these conditions.

Collaborations

Throughout her career, Susan has collaborated with notable colleagues, including Sara Garcia-Rates and Paul Morrill. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of her work.

Conclusion

Susan Adele Greenfield's contributions to the field of neurodegenerative disorders exemplify her commitment to innovation and research. Her patents and ongoing work at Neuro-bio Ltd highlight her role as a leading inventor in this critical area of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…